Effect of cycloastragenol and punicalagin on Prp(106–126) and Aβ(25–35) oligomerization and fibrillizaton

Triazole–Peptide Conjugate as a Modulator of Aβ-Aggregation, Metal-Mediated Aβ-Aggregation, and Cytotoxicity

(2023) Sukhmani Mann et al.   ACS Chemical Neuroscience

Design and synthesis of piano-stool ruthenium(II) complexes and their studies on the inhibition of amyloid β (1–42) peptide aggregation

(2023) Sain Singh et al.   INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES

Exploring the Potential of Pomegranate Peel Extract as a Natural Food Additive: A Review

(2023) Namrata Ankush Giri et al.   Current Nutrition Reports

Inhibition of amyloid β1–42 peptide aggregation by newly designed cyclometallated palladium complexes

(2023) Rahul Saini et al.   International Journal of Biological Macromolecules

An efficient fluorescence chemosensor for sensing Zn(II) ions and applications in cell imaging and detection of Zn(II) induced aggregation of PrP(106–126) peptide

(2023) Govinda R. Navale et al.   JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY A-CHEMISTRY

Antioxidant Therapeutic Strategies in Neurodegenerative Diseases

(2022) Constanza Morén et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Metabolic engineering and synthetic biology for isoprenoid production in Escherichia coli and Saccharomyces cerevisiae

(2021) Govinda R. Navale et al.   APPLIED MICROBIOLOGY AND BIOTECHNOLOGY

The importance of ongoing international surveillance for Creutzfeldt–Jakob disease

(2021) Neil Watson et al.   Nature Reviews Neurology

An updated review on the versatile role of chrysin in neurological diseases: Chemistry, pharmacology, and drug delivery approaches

(2021) Marjan Talebi et al.   BIOMEDICINE & PHARMACOTHERAPY

Therapeutic Potential of Natural Products in Treating Neurodegenerative Disorders and Their Future Prospects and Challenges

(2021) Md. Habibur Rahman et al.   MOLECULES

Mini-review: Amyloid degradation toxicity hypothesis of Alzheimer’s disease

(2021) Dmitry V. Zaretsky et al.   NEUROSCIENCE LETTERS

Green Tea Epigallocatechin-3-gallate (EGCG) Targeting Protein Misfolding in Drug Discovery for Neurodegenerative Diseases

(2021) Priscila Baltazar Gonçalves et al.   Biomolecules

Cycloastragenol inhibits Aβ1–42-induced blood-brain barrier disruption and enhances soluble Aβ efflux in vitro

(2020) Min-Ye Huang et al.   JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH

Prion biology: implications for Alzheimer's disease therapeutics

(2020) Carlo Condello et al.   LANCET NEUROLOGY

Effect of tert-alcohol functional imidazolium salts on oligomerization and fibrillization of amyloid β (1–42) peptide

(2020) Madhukar S. Said et al.   BIOPHYSICAL CHEMISTRY

PrP 106-126 - 25 years after

(2019) Gianluigi Forloni et al.   NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY

The impact of curcumin and its modified formulations on Alzheimer's disease

(2019) Tahereh Farkhondeh et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Protein misfolding, aggregation and mechanism of amyloid cytotoxicity: An overview and therapeutic strategies to inhibit aggregation

(2019) Masihuz Zaman et al.   INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES

Aggregation of PrP106–126 on surfaces of neutral and negatively charged membranes studied by molecular dynamics simulations

(2018) Lulu Ning et al.   BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES

Inhibition of amyloid fibril formation in the variable domain of λ6 light chain mutant Wil caused by the interaction between its unfolded state and epigallocatechin-3-O-gallate

(2018) Yoshito Abe et al.   BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS

Neuroprotective Strategies for Neurological Disorders by Natural Products: An update

(2018) Muneeb U Rehman et al.   Current Neuropharmacology

Photosensitizing materials and platforms for light-triggered modulation of Alzheimer's β-amyloid self-assembly

(2018) Byung Il Lee et al.   BIOMATERIALS

Epidemiological characteristics of human prion diseases

(2016) Cao Chen et al.   Infectious Diseases of Poverty

Neurotrophic Natural Products: Chemistry and Biology

(2013) Jing Xu et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

Inhibition of human prion neuropeptide PrP106-126 aggregation by hexacoordinated ruthenium complexes

(2013) Xuesong Wang et al.   JOURNAL OF INORGANIC BIOCHEMISTRY

Promising in Vitro anti-Alzheimer Properties for a Ruthenium(III) Complex

(2013) Luigi Messori et al.   ACS Medicinal Chemistry Letters

Habitual intake of dietary flavonoids and risk of Parkinson disease

(2012) X. Gao et al.   NEUROLOGY

Palladium Complexes Affect the Aggregation of Human Prion Protein PrP106-126

(2011) Yanli Wang et al.   INORGANIC CHEMISTRY

EGCG remodels mature α-synuclein and amyloid-β fibrils and reduces cellular toxicity

(2010) Jan Bieschke et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Kihi-to, a herbal traditional medicine, improves Abeta(25–35)-induced memory impairment and losses of neurites and synapses

(2008) Chihiro Tohda et al.   BMC Complementary and Alternative Medicine

Quantification of the Binding Constant of Copper(II) to the Amyloid-Beta Peptide

(2008) Lanying Q. Hatcher et al.   JOURNAL OF PHYSICAL CHEMISTRY B

Therapeutics for Alzheimer’s disease based on the metal hypothesis

(2008) Ashley I. Bush et al.   Neurotherapeutics